DIM
HOOK

DC Investments Management’s HOOKIPA Pharma HOOK Stock Holding History

DC Investments Management’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,286
Closed -$288K – 324
2019
Q2 		$288K Buy
+4,286
New +$455K 0.16% 247

Other funds holding HOOK

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DC Investments Management's HOOK Position: Q3 2019 in Review

DC Investments Management sold out of HOOKIPA Pharma (HOOK) in Q3 2019, closing a stake of 4,286 shares — an estimated $288K sold.

DC Investments Management first reported a position in HOOK in Q2 2019 and held it in 1 quarter. The position peaked at $288K in Q2 2019. 35 funds tracked by Wall St. Rank hold HOOK as of Q3 2019.

  • DC Investments Management reported no remaining HOOKIPA Pharma position as of Q3 2019 after selling out during the quarter.
  • DC Investments Management sold 4,286 HOOKIPA Pharma shares in Q3 2019, an estimated $288K.
  • DC Investments Management first reported a position in HOOKIPA Pharma in Q2 2019 and held it in 1 quarter.
  • DC Investments Management's HOOKIPA Pharma position peaked at $288K in Q2 2019.
  • 35 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2019.

Based on DC Investments Management's 13F filing for Q3 2019, filed 5 Nov 2019.